The Bioavailability / Bioequivalence, Dissolution and Biowaivers Conference is one of the leading conferences for clinical, R&D and regulatory teams working with bioequivalence studies, biowaivers and dissolution testing.
It takes place from 14-15 May at the Continental Zara Hotel, Budapest, Hungary.
Join some 22 regulatory authority and industry experts as they share their experience across key developments and challenges facing the industry.
NextPharma’s Head of Analytical Development Dr Peter Andersch will be speaking on the topic of ‘Best practice: development and validation of discriminatory dissolution methods’.
Register for your delegate pass here: www.informa-ls.com/event/babe14.